Compare Marsh & McLennan Companies, Inc. (MRSH) vs Nomura Holdings Inc (NMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marsh & McLennan Companies, Inc. vs Nomura Holdings Inc — how do they compare? Marsh & McLennan Companies, Inc. trades at $180.04 (market cap $87.77B), while Nomura Holdings Inc trades at $9.91 (market cap $27.46B). The key difference: Marsh & McLennan Companies, Inc. is far larger — about 3.2× Nomura Holdings Inc's market cap, and Nomura Holdings Inc pays the higher dividend (3.45%). Which is the better fit depends on your goals.
| MRSH | NMR | |
|---|---|---|
Market Cap | $87.77B | $27.46B |
Sector | Financials | Financials |
52-Week High | $211.21 | $10.04 |
52-Week Low | $157.32 | $6.39 |
Enterprise Value | $108.61B | — |
Dividend Yield | 2.17% | 3.45% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Marsh (MRSH) trades at $181.59, down 0.32% on the day, with a bullish technical signal from moving averages and support at $180. The company reported strong Q2 2026 earnings, beating estimates with $2.96 EPS versus $2.88 expected, driven by 6% revenue growth to $7.4 billion. Fundamentals show robust profitability with a 14.26% net margin and 27.42% ROE, while valuation ratios like P/E of 22.77 and P/S of 3.26 reflect premium pricing. Recent news highlights a 10% dividend increase to $0.99 per share, payable in August 2026.
The outlook for MRSH is positive, supported by consistent earnings beats and strategic AI investments, but risks include rising operating expenses and softer insurance pricing. Analysts maintain a consensus price target of $203.75, implying 12% upside, with 11 buy ratings outweighing 1 sell. Investors should monitor expense management and organic growth sustainability amid competitive pressures.
Nomura Holdings (NMR) trades at $9.81, up 4.36% with a bullish technical signal from moving averages. The company reported record annual profit of $340.74 billion for 2025, with revenue growing to $1.66 trillion and profit margin expanding to 20.49%. Recent news highlights strong wholesale revenue growth exceeding 30% and strategic acquisitions in US asset management. The stock trades at a P/E of 12.77, below industry averages, suggesting potential undervaluation.
Outlook remains positive with continued wholesale business momentum and global expansion initiatives. Key risks include integration costs from recent acquisitions and potential market volatility. Analyst consensus shows 33% buy ratings with no sell recommendations, indicating cautious optimism. The combination of reasonable valuation and strong fundamental performance supports potential upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Marsh & McLennan Companies, Inc.
Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).
Read more on MRSH →About Nomura Holdings Inc
Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →
